Search

Displaying results 7551 - 7560 of 10000 in total
  1. Drug

    Pirenperone

    go.drugbank.com/drugs/DB21405
    Experimental

    The usage of the INN stem '-perone' in the name indicates that Pirenperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  2. Drug

    Cinsebrutinib

    go.drugbank.com/drugs/DB21640
    Experimental

    The usage of the INN stem '-brutinib' in the name indicates that Cinsebrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  3. Drug

    Surzetoclax

    go.drugbank.com/drugs/DB21698
    Investigational

    The usage of the INN stem '-toclax' in the name indicates that Surzetoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor. Surzetoclax has a monoisotopic molecular weight of 1038.41 Da.

  4. Drug

    Apricitabine

    go.drugbank.com/drugs/DB12855
    Investigational

    Apricitabine has been used in trials studying the treatment of HIV Infections.

  5. Drug

    Arazasetron

    go.drugbank.com/drugs/DB19237
    Investigational

    Arazasetron is currently under investigation in clinical trial NCT05258773 (Evaluation of the Presence of SENS-401 in the Perilymph).

  6. Drug

    X-376

    go.drugbank.com/drugs/DB13104
    Investigational

    X-376 is an inhibitor of the anaplastic lymphoma kinase (ALK) which can penetrate the blood brain barrier.[A265085]

  7. Drug

    R112

    go.drugbank.com/drugs/DB06252
    Experimental

    R112 is an investigational compound developed to treat Allergic Rhinitis. It's mechanism of action is to inhibit SYK kinase.

  8. Drug

    Phosphonothreonine

    go.drugbank.com/drugs/DB02482
    Experimental

    The phosphoric acid ester of threonine. Used as an identifier in the analysis of peptides, proteins, and enzymes. [PubChem]

  9. Drug

    D-arginine

    go.drugbank.com/drugs/DB04027
    Experimental

    A D-α-amino acid that is the D-isomer of arginine (only the L-form is physiologically active).

  10. Drug

    Foselutoclax

    go.drugbank.com/drugs/DB21663
    Investigational

    The usage of the INN stem '-toclax' in the name indicates that Foselutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor. … Foselutoclax is under investigation in clinical trial NCT06011798 (Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)).